XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (UNAUDITED) - USD ($)
$ in Thousands
Total
Series Seed 0 - 10 [Member]
Series A Convertible Preferred Stock
Series A-1 [Member]
Series A-2 [Member]
Common Stock [Member]
Common Stock [Member]
Class A Common Stock
Common Stock [Member]
Class B Common Stock
Additional Paid In Capital
Accumulated Other Comprehensive (Income) Loss
Accumulated Deficit
Beginning balance, shares at Dec. 31, 2021   42,999 86,703 10,208              
Beginning balance at Dec. 31, 2021   $ 7,594 $ 19,535 $ 2,604              
Beginning balance at Dec. 31, 2021 $ (19,663)           $ 3   $ 37,806 $ (159) $ (57,313)
Beginning balance, shares at Dec. 31, 2021             181,362 31,703      
Issuance of stock 2,063           $ 3   2,060    
Issuance of stock, shares             267,384        
Issuance of Series A-2 preferred stock upon conversion of convertible notes, shares         124,313            
Issuance of Series A-2 preferred stock upon conversion of convertible notes         $ 5,926            
Issuance of Series A-2 preferred stock, net of issuance costs, shares         631,292            
Issuance of Series A-2 preferred stock, net of issuance costs         $ 30,028            
Issuance of Class B common stock upon exercise of stock options 8               8    
Issuance of Class B common stock upon exercise of stock options, shares               501      
Stock-based compensation 97               97    
Foreign currency translation (loss) gain 167                 167  
Net loss (12,691)                   (12,691)
Ending balance, shares at Mar. 31, 2022   42,999 86,703 10,208 755,605            
Endng balance at Mar. 31, 2022   $ 7,594 $ 19,535 $ 2,604 $ 35,954            
Ending balance at Mar. 31, 2022 (30,019)           $ 6   39,971 8 (70,004)
Ending balance, shares at Mar. 31, 2022             448,746 32,204      
Beginning balance at Dec. 31, 2022 (2,733)           $ 4   112,436 365 (115,538)
Beginning balance, shares at Dec. 31, 2022             2,416,698 34,224      
Issuance of stock 4,452         $ 3     4,449    
Issuance of stock, shares           8,676,924          
Issuance of Common stock upon conversion of Common Stock 0         $ 4 $ 4        
Issuance of Common stock upon conversion of Common Stock, shares           2,416,698 (2,416,698)        
Issuance of Class B common stock upon exercise of stock options 14               14    
Issuance of Class B common stock upon exercise of stock options, shares               646,433      
Common stock converted, shares           680,657   (680,657)      
Stock-based compensation 15,057               15,057    
Net exercise of options 323               323    
Foreign currency translation (loss) gain (115)                 (115)  
Net loss (15,961)                   (15,961)
Ending balance at Mar. 31, 2023 $ 1,037         $ 7     $ 132,279 $ 250 $ (131,499)
Ending balance, shares at Mar. 31, 2023           11,774,279